These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8395335)
1. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma. Barnard GF; Staniunas RJ; Mori M; Puder M; Jessup MJ; Steele GD; Chen LB Cancer Res; 1993 Sep; 53(17):4048-52. PubMed ID: 8395335 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. Barnard GF; Staniunas RJ; Bao S; Mafune K; Steele GD; Gollan JL; Chen LB Cancer Res; 1992 Jun; 52(11):3067-72. PubMed ID: 1350508 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Kondoh N; Schweinfest CW; Henderson KW; Papas TS Cancer Res; 1992 Feb; 52(4):791-6. PubMed ID: 1339304 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma. Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155 [TBL] [Abstract][Full Text] [Related]
5. Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Mafune K; Ravikumar TS; Wong JM; Yow H; Chen LB; Steele GD Cancer Res; 1990 Jul; 50(13):3888-91. PubMed ID: 2141294 [TBL] [Abstract][Full Text] [Related]
6. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Husain I; Mohler JL; Seigler HF; Besterman JM Cancer Res; 1994 Jan; 54(2):539-46. PubMed ID: 8275492 [TBL] [Abstract][Full Text] [Related]
7. Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Lu XQ; Levy M; Weinstein IB; Santella RM Cancer Res; 1991 Dec; 51(23 Pt 1):6231-5. PubMed ID: 1933883 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161 [TBL] [Abstract][Full Text] [Related]
9. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Henry JL; Coggin DL; King CR Cancer Res; 1993 Mar; 53(6):1403-8. PubMed ID: 8095182 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer. Barnard GF; Mori M; Staniunas RJ; Begum NA; Bao S; Puder M; Cobb J; Redman KL; Steele GD; Chen LB Biochim Biophys Acta; 1995 Dec; 1272(3):147-53. PubMed ID: 8541345 [TBL] [Abstract][Full Text] [Related]
11. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. D'Errico A; Garbisa S; Liotta LA; Castronovo V; Stetler-Stevenson WG; Grigioni WF Mod Pathol; 1991 Mar; 4(2):239-46. PubMed ID: 1646457 [TBL] [Abstract][Full Text] [Related]
12. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067 [TBL] [Abstract][Full Text] [Related]
13. Detection of mRNA for ribosomal phosphoprotein P2 in normal colon and colonic tumours by in situ hybridization. Harvie R; Elvin P; McArdle C; Morten JE; McNicol AM J Pathol; 1991 May; 164(1):67-73. PubMed ID: 2056390 [TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Kondoh N; Shuda M; Tanaka K; Wakatsuki T; Hada A; Yamamoto M Anticancer Res; 2001; 21(4A):2429-33. PubMed ID: 11724303 [TBL] [Abstract][Full Text] [Related]
15. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas. Dragović T; Deddish PA; Tan F; Weber G; Erdös EG Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152 [TBL] [Abstract][Full Text] [Related]
18. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma. Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139 [TBL] [Abstract][Full Text] [Related]
19. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Kitadai Y; Ellis LM; Takahashi Y; Bucana CD; Anzai H; Tahara E; Fidler IJ Clin Cancer Res; 1995 Oct; 1(10):1095-102. PubMed ID: 9815899 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]